Business

Merck’s Covid drug will do it now, just in time for Omicron

Last month, the UK became the first country to approve molnupiravir, a Covid-19 treatment developed by Ridgeback Biotherapeutics and Merck & Co. manufacture. On Tuesday, an advisory panel convened by the US Food and Drug Administration voted in favor of authorizing emergency use of the antiviral as well. But between the two approvals, Merck released some data that showed the drug was less effective than initially thought and far less effective than a rival drug from Pfizer, the company’s Also asking for permission for emergency use.

https://www.washingtonpost.com/business/mercks-covid-drug-will-do-for-now-just-in-time-for-omicron/2021/12/01/4c0894da-52d8-11ec-83d2-d9dab0e23b7e_story.html?utm_source=rss&utm_medium=referral&utm_campaign=wp_business Merck’s Covid drug will do it now, just in time for Omicron

snopx

Inter Reviewed is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – admin@interreviewed.com. The content will be deleted within 24 hours.

Related Articles

Back to top button